ReviewWorld journal of gastroenterology2014

Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation.

Xing-Chun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.